PATENT CLAIM ANALYSIS

Application Number: 15767618
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "231100"]

Abstract:
The disclosure relates to herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 18):
The vaccine of any one of  claims 15 - 17 , wherein the chemical modification is a N1-methylpseudouridine or N1-ethylpseudouridine.

Metadata:
- Claim Count in Document: 70.0
- Percentile: 91.0
- Lexical Diversity: 1.24
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15674585', '15674591', '15674599', '15674569', '15091123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7540011481677192
- 35 USC 102 Novelty (BERT): 0.5621615245443486
- Combined Prediction Score: 0.7348171858053822
- Mean Citation Score: 413.72095800000005
- Max Citation Score: 439.89752
- Similarity Product: 333.7875127415895

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test